- Home
- HTBK vs ALLO Comparison
HTBK vs ALLO Comparison
Compare HTBK & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTBK | ALLO |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 739.7M | 707.6M |
| IPO Year | 1998 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HTBK | ALLO |
|---|---|---|
| Price | $13.45 | $1.88 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 15 |
| Target Price | ★ $12.88 | $8.35 |
| AVG Volume (30 Days) | 1.2M | ★ 7.1M |
| Earning Date | 04-24-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | 18.18 | ★ 34.09 |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $3,688,000.00 | N/A |
| Revenue This Year | $7.80 | N/A |
| Revenue Next Year | $5.51 | $142,416.42 |
| P/E Ratio | $17.24 | ★ N/A |
| Revenue Growth | ★ 3.57 | N/A |
| 52 Week Low | $9.02 | $0.99 |
| 52 Week High | $13.83 | $4.46 |
Technical Indicators
Market Signals| Indicator | HTBK | ALLO |
|---|---|---|
| Relative Strength Index (RSI) | 64.54 | 40.44 |
| Support Level | $11.85 | $1.85 |
| Resistance Level | $13.65 | $1.92 |
| Average True Range (ATR) | 0.31 | 0.13 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 81.90 | 21.93 |
Price Performance
Historical ComparisonAbout HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. Majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).